E2A activators are molecules that play a pivotal role in modulating the biological activity of the E2A family of transcription factors. Transcription factors are proteins that bind to specific DNA sequences to control the rate of transcription of genetic information from DNA to messenger RNA (mRNA). The E2A family belongs to the class of basic helix-loop-helix (bHLH) transcription factors. These bHLH domains are critical for DNA binding and dimerization with other bHLH proteins. E2A activators specifically increase or enhance the activity of E2A transcription factors. This action can subsequently lead to the transcriptional regulation of a range of target genes, which in turn affects a variety of biological processes.
The molecular mechanisms of action for E2A activators can be diverse. Some E2A activators might act by directly binding to the E2A protein, thereby promoting its stabilization or enhancing its DNA-binding activity. Others might function indirectly, by inhibiting negative regulators of E2A or by modulating cellular pathways that, in turn, influence E2A activity. Furthermore, the activity of E2A transcription factors can be influenced by post-translational modifications like phosphorylation, ubiquitination, or acetylation. Therefore, molecules that modulate these modifications can also act as E2A activators. Understanding the intricate nuances of how E2A activators operate is pivotal for deciphering the role of the E2A family in the complex network of transcriptional regulation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, 5-azacytidine can affect gene expression patterns. It could potentially modulate E2A expression, though direct evidence might be needed. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This is a histone deacetylase inhibitor. By inhibiting HDACs, Trichostatin A can modify the chromatin structure, potentially affecting E2A expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
This mTOR inhibitor affects several cellular processes, and it could potentially have an indirect impact on E2A activity. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
As a glucocorticoid, dexamethasone can modulate the expression of numerous genes. Its effect on E2A would need further investigation. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Another HDAC inhibitor, which by affecting chromatin structure, could potentially modulate E2A expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Known for its role in activating the sirtuin pathway, it could also have a potential effect on E2A, though direct evidence might be needed. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
This proteasome inhibitor affects NF-kB activity and might have indirect effects on other transcription factors, potentially including E2A. | ||||||